Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation

Monodispersed and Ordered Large-Pore Mesoporous Silica Nanospheres with Tunable Pore Structure for Magnetic Functionalization and Gene Delivery

(2014) Dechao Niu et al.   ADVANCED MATERIALS

Protein Adsorption into Mesopores: A Combination of Electrostatic Interaction, Counterion Release, and van der Waals Forces

(2014) Sebastian T. Moerz et al.   LANGMUIR

Acylation of Exenatide by Glycolic Acid and its Anti-Diabetic Activities in db/db Mice

(2014) Rongcai Liang et al.   PHARMACEUTICAL RESEARCH

Comparative Studies on the Influences of Primary Emulsion Preparation on Properties of Uniform-Sized Exenatide-Loaded PLGA Microspheres

(2014) Feng Qi et al.   PHARMACEUTICAL RESEARCH

Rapidly Dissolvable Microneedle Patches for Transdermal Delivery of Exenatide

(2014) Zhuangzhi Zhu et al.   PHARMACEUTICAL RESEARCH

Oral Delivery of Exenatide via Microspheres Prepared by Cross-Linking of Alginate and Hyaluronate

(2014) Baojie Zhang et al.   PLoS One

In Vivo Bio-Safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles

(2013) Yu Chen et al.   ADVANCED MATERIALS

Synthesis of mesoporous silica nanoparticles

(2013) Si-Han Wu et al.   CHEMICAL SOCIETY REVIEWS

In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes

(2013) Lejiao Jia et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan

(2013) Sukyung Ahn et al.   JOURNAL OF CONTROLLED RELEASE

Exenatide-loaded PLGA microspheres with improved glycemic control: In vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats

(2013) Jiming Xuan et al.   PEPTIDES

Mesoporous silica nanoparticles in medicine—Recent advances

(2012) Veronika Mamaeva et al.   ADVANCED DRUG DELIVERY REVIEWS

The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo

(2011) Ho-Ngoc Nguyen et al.   BIOMATERIALS

Preparation, Characterization, and Pharmacodynamics of Exenatide-Loaded Poly(DL-lactic-co-glycolic acid) Microspheres

(2010) Bin Liu et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

(2010) Yong Zhang et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Efficacy of a new sustained-release microsphere formulation of exenatide, DA-3091, in Zucker diabetic fatty (ZDF) rats

(2010) Hyun-Hee Kwak et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Exenatide: a review from pharmacology to clinical practice

(2009) R. Gentilella et al.   DIABETES OBESITY & METABOLISM

Pharmacokinetics and Efficacy of a Biweekly Dosage Formulation of Exenatide in Zucker Diabetic Fatty (ZDF) Rats

(2009) Hyun-Hee Kwak et al.   PHARMACEUTICAL RESEARCH

The biocompatibility of mesoporous silicates

(2008) Sarah P. Hudson et al.   BIOMATERIALS

Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration

(2008) Bronislava R. Gedulin et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state

(2008) Luis Arnés et al.   REGULATORY PEPTIDES